Search

everythinglearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Gene variation affects prostate issues and hair loss.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Prolactin affects when mice shed and grow hair.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Prolactin affects when mice shed and grow hair.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Lowering testosterone speeds up wound healing in male mice.

Activating TRPV3 stops human hair growth.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Minoxidil boosts hair growth by targeting adenosine and possibly sulfonylurea receptor 2B.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Skin has specialized touch receptors that can tell different sensations apart.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.